KemPharm Inc.

03/02/2021 | Press release | Distributed by Public on 03/02/2021 22:36

KemPharm Announces FDA Approval of AZSTARYS™ (serdexmethylphenidate and dexmethylphenidate capsules, for oral use, CII), A New Once-Daily Treatment for ADHD